article instance (Q110063)

From ScienceSource
Jump to: navigation, search
No description defined
edit
Language Label Description Also known as
English
article instance
No description defined

    Statements

    Cost-Effectiveness of Saxagliptin versus Acarbose as Second-Line Therapy in Type 2 Diabetes in China (5119856)
    0 references
    Q28553675
    0 references
    Cost-Effectiveness of Saxagliptin versus Acarbose as Second-Line Therapy in Type 2 Diabetes in China
    0 references
    22 November 2016
    0 references
    17 April 2019
    0 references
    0
    0 references
    no value
    0 references
    no value
    0 references
    no value
    0 references
    0 references
    111,982
    0 references
     
    edit
      edit
        edit
          edit
            edit
              edit